Frantz Medical Ventures Fund I, L.P. (FMV) is a limited partnership whose objective is long-term capital appreciation through venture capital investments in early and expansion-stage technology companies. 

The Fund is a unique partnership of:

• Experienced medical research and development professionals
• An innovative, biomedical research and manufacturing operating company, Frantz Medical Group, and
• Financial experts

Focus and Opportunity

FMV invests in companies with proprietary, innovative technology in the fields of Medical Devices, Diagnostics, Biotechnology and Biomedical Software.

Investment Process

The due diligence process is a disciplined, scientific approach utilizing in-house resources (Fund management, Frantz Medical Group and SAB) to fully vet each opportunity considering all facets of technology, clinical need, regulatory approval, manufacturing and commercialization.

Portfolio Company Support

As the portfolio companies face the challenges of product development and commercialization, the Frantz Medical Group's team of experts is available to provide guidance on the full range of issues common to operating companies in the medical industry. This value-added assistance is relatively unique in the venture capital industry. There are a number of VC professionals with industry experience, and they are able to call upon functional experts to assist the companies, however, it is rare to find an operating company - Frantz Medical Group - as a committed, dedicated member of a fund.